Label free nano-aptasensor for interleukin-6 in protein-dilute bio fluids such as sweat

2016 ◽  
Vol 8 (17) ◽  
pp. 3440-3444 ◽  
Author(s):  
L. S. Selva Kumar ◽  
Xiao Wang ◽  
Joshua Hagen ◽  
Rajesh Naik ◽  
Ian Papautsky ◽  
...  
Keyword(s):  
Gold Nanoparticle ◽  
Modified Electrode ◽  
Interleukin 6 ◽  
Limit Of Detection ◽  
Label Free ◽  
Artificial Sweat

A sub-pM limit of detection label-free sensor is presented for interleukin-6 based on impedimetric measurement of a gold nanoparticle/aptamer-modified electrode in artificial sweat.

scholarly journals Plasmonic nanocrystals on polycarbonate substrates for direct and label-free biodetection of Interleukin-6 in bioengineered 3D skeletal muscles

Nanophotonics ◽  
2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Gerardo A Lopez-Muñoz ◽  
Juan M Fernández-Costa ◽  
Maria Alejandra Ortega ◽  
Jordina Balaguer-Trias ◽  
Eduard Martin-Lasierra ◽  
...  
Keyword(s):  
Interleukin 6 ◽  
Limit Of Detection ◽  
Culture Media ◽  
Incident Angle ◽  
Wide Field ◽  
Label Free ◽  
Cell Culture Media ◽  
Muscle Tissues ◽  
Label Free Detection ◽  
Potential Benefits

Abstract The development of nanostructured plasmonic biosensors has been widely widespread in the last years, motivated by the potential benefits they can offer in integration, miniaturization, multiplexing opportunities, and enhanced performance label-free biodetection in a wide field of applications. Between them, engineering tissues represent a novel, challenging, and prolific application field for nanostructured plasmonic biosensors considering the previously described benefits and the low levels of secreted biomarkers (≈pM–nM) to detect. Here, we present an integrated plasmonic nanocrystals-based biosensor using high throughput nanostructured polycarbonate substrates. Metallic film thickness and incident angle of light for reflectance measurements were optimized to enhance the detection of antibody–antigen biorecognition events using numerical simulations. We achieved an enhancement in biodetection up to 3× as the incident angle of light decreases, which can be related to shorter evanescent decay lengths. We achieved a high reproducibility between channels with a coefficient of variation below 2% in bulk refractive index measurements, demonstrating a high potential for multiplexed sensing. Finally, biosensing potential was demonstrated by the direct and label-free detection of interleukin-6 biomarker in undiluted cell culture media supernatants from bioengineered 3D skeletal muscle tissues stimulated with different concentrations of endotoxins achieving a limit of detection (LOD) of ≈ 0.03 ng/mL (1.4 pM).

Quantitative Determination of Triiodothyronine by Electrochemical Impedance Spectroscopic Biosensor Using Gold Nanoparticle-Modified Electrode

2020 ◽  
Vol 20 (11) ◽  
pp. 7163-7168
Author(s):  
Huynh Vu Nguyen ◽  
Anna Go ◽  
Min-Ho Lee
Keyword(s):  
Quantitative Determination ◽  
Gold Nanoparticle ◽  
Modified Electrode ◽  
Electrochemical Impedance ◽  
Low Cost ◽  
Charge Transfer Resistance ◽  
Impedance Change ◽  
Label Free ◽  
Transfer Resistance

A label-free electrochemical impedimetric immunosensor for the detection of Triiodothyronine—a thyroid hormone that functions as the biomarker for monitoring for thyroid dysfunction was developed. The gold nanoparticle-modified electrode was employed to achieve the sensitive determination of Triiodothyronine at a low concentration level. The gold nanoparticle layer on the gold electrode was generated by chronoamperometry method and its resulting characteristics were investigated by scanning electron microscopy. Redox probe [Fe(CN)6]3−/4− and electrochemical impedance spec-troscopy was used for both evaluation of the immobilization of anti-Triiodothyronine antibody on the electrode surface and quantitative determination of target Triiodothyronine in different concentrations. The electrode with absorbed antibodies showed significant changes in charge transfer resistance upon binding the antigen, which resulted in an increase in normalized impedance change as the addition of antigen concentrations over a dynamic linear range of 0.01–100 ng/ml. These results indicated that the proposed immunosensor could be a potential alternative method for determination of Triiodothyronine in clinics with the advantage of low cost and less time-consuming.

A label-free immunosensor for the detection of a new lung cancer biomarker, GM2 activator protein, using a phosphomolybdic acid/polyethyleneimine coated gold nanoparticle composite

The Analyst ◽  
2021 ◽  
Author(s):  
Kulrisa Kuntamung ◽  
Padchanee Sangthong ◽  
Jaroon Jakmunee ◽  
Kontad Ounnunkad
Keyword(s):  
Lung Cancer ◽  
Gold Nanoparticle ◽  
Modified Electrode ◽  
Phosphomolybdic Acid ◽  
Cancer Biomarker ◽  
Electrochemical Immunosensor ◽  
Label Free ◽  
Gm2 Activator ◽  
Lung Cancer Biomarker ◽  
Gm2 Activator Protein

A novel electrochemical immunosensor for the detection of a new lung cancer biomarker based on a polyoxometalate-adsorbed poly(ethylenimine)-coated gold nanoparticle modified electrode.

Enhanced Charge Transfer by Gold Nanoparticle at DNA Modified Electrode and Its Application to Label-Free DNA Detection

2014 ◽  
Vol 6 (10) ◽  
pp. 7579-7584 ◽  
Author(s):  
Yucai Yang ◽  
Chao Li ◽  
Li Yin ◽  
Muyun Liu ◽  
Zhaoxia Wang ◽  
...  
Keyword(s):  
Charge Transfer ◽  
Gold Nanoparticle ◽  
Modified Electrode ◽  
Dna Detection ◽  
Label Free ◽  
Free Dna

A Point of Care Lateral Flow Assay for Rapid and Colorimetric Detection of Interleukin 6 and Perspectives in Bedside Diagnostics

2020 ◽  
Author(s):  
Carla Eiras
Keyword(s):  
Interleukin 6 ◽  
Limit Of Detection ◽  
Inflammatory Diseases ◽  
Point Of Care ◽  
Colorimetric Detection ◽  
Lateral Flow ◽  
Lateral Flow Assay ◽  
Aggregation Assay ◽  
Before And After ◽  
Bedside Diagnosis

Interleukin-6 (IL-6) is a multifunctional cytokine and high bloodstream levels of which have been associated with severe inflammatory diseases, such as dengue fever, sepsis, various cancers, and visceral leishmaniasis (VL). Rapid tests for the quantification of IL-6 would be of great assistance for the bedside diagnosis and treatment of diseases such as VL. We have developed a lateral flow assay (LFA) for rapid and colorimetric IL-6 detection, consisting of anti-IL-6 antibodies conjugated to gold nanoparticles (AuNPs). The optimal concentration of anti-IL-6 used in the conjugate was determined to be 800.0 μg/mL, based on an aggregation assay using LFA. A linear relationship between IL-6 standard concentration and color intensity was observed after 20 min, with a linear range between 1.25 ng/mL and 9,000 ng/mL. The limit of detection for this method was estimated a t0.38 ng/mL. The concentration of IL-6 in five patients with severe VL was measured using LFA, and the results were consistent with those obtained using the cytometric bead array (CBA) method. A thorough analysis of the LFA membranes’ surface morphology, before and after sample contact, was performed using atomic force microscopy (AFM).The prototype described here is still being tested and improved, but this LFA will undoubtedly be of great help in the clinical quantification of IL-6.

A Point of Care Lateral Flow Assay for Rapid and Colorimetric Detection of Interleukin 6 and Perspectives in Bedside Diagnostics

2020 ◽  
Author(s):  
Carla Eiras
Keyword(s):  
Interleukin 6 ◽  
Limit Of Detection ◽  
Inflammatory Diseases ◽  
Point Of Care ◽  
Colorimetric Detection ◽  
Lateral Flow ◽  
Lateral Flow Assay ◽  
Aggregation Assay ◽  
Before And After ◽  
Bedside Diagnosis

Interleukin-6 (IL-6) is a multifunctional cytokine and high bloodstream levels of which have been associated with severe inflammatory diseases, such as dengue fever, sepsis, various cancers, and visceral leishmaniasis (VL). Rapid tests for the quantification of IL-6 would be of great assistance for the bedside diagnosis and treatment of diseases such as VL. We have developed a lateral flow assay (LFA) for rapid and colorimetric IL-6 detection, consisting of anti-IL-6 antibodies conjugated to gold nanoparticles (AuNPs). The optimal concentration of anti-IL-6 used in the conjugate was determined to be 800.0 μg/mL, based on an aggregation assay using LFA. A linear relationship between IL-6 standard concentration and color intensity was observed after 20 min, with a linear range between 1.25 ng/mL and 9,000 ng/mL. The limit of detection for this method was estimated at a t0.38 ng/mL. The concentration of IL-6 in five patients with severe VL was measured using LFA, and the results were consistent with those obtained using the cytometric bead array (CBA) method. A thorough analysis of the LFA membranes’ surface morphology, before and after sample contact, was performed using atomic force microscopy (AFM). The prototype described here is still being tested and improved, but this LFA will undoubtedly be of great help in the clinical quantification of IL-6.

scholarly journals Demonstration of a Label-Free and Low-Cost Optical Cavity-Based Biosensor Using Streptavidin and C-Reactive Protein

Biosensors ◽  
2020 ◽  
Vol 11 (1) ◽  
pp. 4
Author(s):  
Donggee Rho ◽  
Seunghyun Kim
Keyword(s):  
Limit Of Detection ◽  
Point Of Care ◽  
Low Cost ◽  
Optical Cavity ◽  
Sample Volume ◽  
Small Sample ◽  
Label Free ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Cavity Structure

An optical cavity-based biosensor (OCB) has been developed for point-of-care (POC) applications. This label-free biosensor employs low-cost components and simple fabrication processes to lower the overall cost while achieving high sensitivity using a differential detection method. To experimentally demonstrate its limit of detection (LOD), we conducted biosensing experiments with streptavidin and C-reactive protein (CRP). The optical cavity structure was optimized further for better sensitivity and easier fluid control. We utilized the polymer swelling property to fine-tune the optical cavity width, which significantly improved the success rate to produce measurable samples. Four different concentrations of streptavidin were tested in triplicate, and the LOD of the OCB was determined to be 1.35 nM. The OCB also successfully detected three different concentrations of human CRP using biotinylated CRP antibody. The LOD for CRP detection was 377 pM. All measurements were done using a small sample volume of 15 µL within 30 min. By reducing the sensing area, improving the functionalization and passivation processes, and increasing the sample volume, the LOD of the OCB are estimated to be reduced further to the femto-molar range. Overall, the demonstrated capability of the OCB in the present work shows great potential to be used as a promising POC biosensor.

Label-free electrochemical immunosensor based on gold nanoparticle/polyethyleneimine/reduced graphene oxide nanocomposite for the ultrasensitive detection of cancer biomarker matrix metalloproteinase-1

The Analyst ◽  
2021 ◽  
Author(s):  
Xinke Liu ◽  
Lu-Yin Lin ◽  
Fu-Yen Tseng ◽  
Yu-Cheng Tan ◽  
Jian Li ◽  
...  
Keyword(s):  
Graphene Oxide ◽  
Matrix Metalloproteinase ◽  
Gold Nanoparticle ◽  
Reduced Graphene Oxide ◽  
Electrochemical Immunosensor ◽  
Ultrasensitive Detection ◽  
Label Free ◽  
Matrix Metalloproteinase 1 ◽  
Reduced Graphene ◽  
P Matrix

Matrix metalloproteinase-1 (MMP-1) is associated with many types of cancers, including oral, colorectal, and brain cancers. This paper describes the fabrication of an MMP-1 immunosensor based on a gold nanoparticle/polyethyleneimine/reduced...

Sign in / Sign up

Export Citation Format

Share Document